comparemela.com

Latest Breaking News On - Glycated hemoglobin - Page 16 : comparemela.com

Artificial Pancreas Best in Poorly Controlled Type 1 Diabetes

Improvements compared to usual care of multiple daily insulin injections and intermittently scanned CGM were larger than those seen in prior trials of hybrid closed-loop systems.

United kingdomUnited statesMedtronic minimedPratik choudharyPeterg jacobsUniversity hospitals leicesterLeciester diabetes centreKing college hospitalDiabetes technology networkInsulet corporationOregon health science universityNovo nordiskThelancet diabetesAbbott freestyleOregon healthScience university

Earlier Is Better: Treat Patients Before Type 2 Diabetes Develops

Ralph DeFronzo, MD, discusses treating type 2 diabetes early and using drugs to correct the pathophysiologic disturbances associated with it.

United statesBanting lectureDiabetes controlComplications trialUnited kingdom prospective diabetes studyDiabetes careDiabetes mellitus type 2Iabetes mellitus type iiType 2 diabetesDiabetes mellitusDrug developmentNdocrine systemHemoglobin a1cHemoglobin a1c testGlycated hemoglobinGlycosylated hemoglobin

NSAIDs Linked to Heart Failure Risk in Diabetes

A Danish case-crossover study found that NSAID use increased heart failure risks 50% in patients with diabetes.

United statesAnn arborNew zealandAnders holtAveritas pharmaRodica busuiCopenhagen universityAmerican college of cardiologyUniversity of auckland new zealandBoehringer ingelheimAmerican diabetes associationUniversity of michiganLilly allianceRegenacy pharmaceuticalsDanish heart foundationEuropean society of cardiology

Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19

A new study examines the potential benefit of the glucokinase activator molecule AZD1656 in the ARCADIA trial.

Fahroni shutterstockMulticentre clinical trialDiabetic patients hospitalised withTherapeutic immuneImage creditAtrial cardiopathyAntithrombotic drugsPrevention after cryptogenic strokeMet tregsCoronavirus disease covid 19Anti inflammatoryClinical trialGlycated hemoglobinImmune responseN vivoArs cov 2

Medicare Advantage Tied to Less Use of Pricey Diabetes Drugs

Data from more than 400,000 Medicare beneficiaries showed a significant link between less prescribing of SGLT2 inhibitors and GLP-1 agonists and enrollment in a Medicare Advantage plan.

United statesUtiber essienDiana degetteCenters for medicareHealth equity researchUniversity of pittsburghUs congressMedicaid servicesHouse of representative energyMedicare advantageRepresentative diana degetteRepresentative energyCommerce subcommitteeDiabetes collaborative registrySystemic useHealthcare system

vimarsana © 2020. All Rights Reserved.